Babor T , Caetano R , Casswell S , Edwards G , Geisbrecht N , Graham K , Grube J , Gruenwald P , Hill L , Holder H , Homel R , Osterberg E , Rehm J , Room R , Rossow I (2003) Alcohol: No Ordinary Commodity: Research and Public Policy. Oxford University Press, Oxford
2.
Gahlinger P M (2004) Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine (methylenedioxymethamphetamine) . Am Fam Physician69: 2619–2626
3.
Healy D (2004) Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression. New York University Press, New York
4.
Insight Team of the Sunday Times (1979) Suffer the Children: The Story of Thalidomide. Andre Deutsch, London
5.
McAllister W B (2000) Drug Diplomacy in the Twentieth Century: An International History. Routledge, London
6.
Moynihan R , Cassels A (2005) Selling Sickness: How the Drug Companies are Turning us all into Patients. Allen & Unwin, Crows Nest, NSW
7.
Ragan C I (2005) Drugs Futures 2025? Perspective of the Pharmaceutical Industry. Foresight Programme, Department of Trade and Industry, London
8.
Stratton K , Shetty P , Wallace R , Bandurant S (2001) Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. National Academy Press, Washington, DC
